Biomarkers to Target Heterogeneous Breast Cancer Stem Cells


Breast cancer is the most common cancer and the second leading cause of death in U.S. women. Due to early detection and advanced treatment, the breast cancer death rate has been declining since 1990. However, disease recurrence is still the major obstacle in moving from therapy to truly curative treatments. Recent evidence has indicated that breast cancer… (More)

1 Figure or Table


  • Presentations referencing similar topics